Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta et al, 2023, Molecular Aspects of Medicine CrossRef
Perspectives on Antiviral Drugs Development in the Treatment of COVID-19
Aura Rusu et al, 2021, Acta Biologica Marisiensis CrossRef
Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series
Brandon Iturbe Esquivel et al, 2022, Monaldi Archives for Chest Disease CrossRef
Repurposing of Chemotherapeutics to Combat COVID-19
Sisir Nandi et al, 2022, Current Topics in Medicinal Chemistry CrossRef
Strategies for drug repurposing against coronavirus targets
Poppy O. Smith et al, 2022, Current Research in Pharmacology and Drug Discovery CrossRef
Nanomaterials for Photocatalytic Degradations of Analgesic, Mucolytic and Anti-Biotic/Viral/Inflammatory Drugs Widely Used in Controlling SARS-CoV-2
Mahsa Ebrahimi et al, 2022, Catalysts CrossRef
Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital
Krista Yazareth Enríquez López et al, 2021, Cureus CrossRef
Can anti-parasitic drugs help control COVID-19?
Yasin Panahi et al, 2022, Future Virology CrossRef
Fast one-pot microwave-assisted green synthesis of highly fluorescent plant-inspired S,N-self-doped carbon quantum dots as a sensitive probe for the antiviral drug nitazoxanide and hemoglobin
Nermeen A. Qandeel et al, 2023, Analytica Chimica Acta CrossRef
Post COVID-19 complications, adjunct therapy explored, and steroidal after effects
Charu Sonkar et al, 2022, Canadian Journal of Chemistry CrossRef
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
Simiso Sokhela et al, 2022, Journal of Antimicrobial Chemotherapy CrossRef
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects
Mina T. Kelleni, 2022, Expert Review of Anti-infective Therapy CrossRef